Atomexetine
Sold as Attentra, Attencit, Xethera, Atteze, Pellego, Atomaktin, Inir
No structure available
This product's active ingredient could not be matched to a single known compound.
Background
Registration
- Applicants
- 7
- Registrations
- 31
- Schedule source
- SAHPRA documentation
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Teva Pharmaceuticals (Pty) Ltd | Attentra | 10, 18, 40, 60, 61 | 500591, 500592, 500594, 500595, 500596 | S5 | PIPIL |
| Pharma Dynamics (Pty) Ltd | Attencit | 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg, 100mg | 510376, 510377, 510378, 510379, 510380, 510381, 510382 | Not determined | None |
| Viatris South Africa (Pty) Ltd | Xethera | 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg | 510988, 510989, 510990, 510991, 510992, 510993 | Not determined | None |
| Adcock ingram limitedCancelled | Atteze | 10, 18, 25, 40, 60 | 511044, 511045, 511046, 511047, 511048 | Not determined | None |
| Aurogen South Africa (Pty) LtdCancelled | Pellego | 40 mg | 530036.031 | Not determined | None |
| Macleods Pharmaceuticals SA (Pty) Ltd | Atomaktin | 10, 18, 25, 40, 60, 80 | 561141, 561142, 561143, 561144, 561145, 561146 | S5 | PIPIL |
| Dr Reddyæs Laboratories (Pty) LtdCertificate held by Dr. Reddy’s Laboratories (Pty) Ltd | Inir | 80 mg | 570370 | S5 | PIPIL |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Attentra 10 EACH CAPSULE CONTAINS :ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 10,0 mg | 10Capsules | 50059150/1.2/0591Approved 9 July 2025 | Registered | S5 | PIPIL |
| Attentra 18 EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 18,0 mg | 18Capsules | 50059250/1.2/0592Approved 9 July 2025 | Registered | S5 | PIPIL |
| Attentra 40 EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 40,0 m | 40Capsules | 50059450/1.2/0594Approved 9 July 2025 | Registered | S5 | PIPIL |
| Attentra 60 EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 60,0 mg | 60Capsules | 50059550/1.2/0595Approved 9 July 2025 | Registered | S5 | PIPIL |
| Attentra 61 EACH CAPSULE COTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 80,0 mg | 61Capsules | 50059650/1.2/0596Approved 9 July 2025 | Registered | S5 | PIPIL |
| Attencit 10 MG EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 10,0 mg | 10 mg | 51037651/1.2/0376 | Registered | Not determined | None |
| Attencit 18 MG EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 18,0 mg | 18 mg | 51037751/1.2/0377 | Registered | Not determined | None |
| Attencit 25 MG EACH CAPSULE CONTAINS ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 25,0 mg | 25 mg | 51037851/1.2/0378 | Registered | Not determined | None |
| Attencit 40 MG EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 40,0 mg | 40 mg | 51037951/1.2/0379 | Registered | Not determined | None |
| Attencit 60 MG EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 60,0 mg | 60 mg | 51038051/1.2/0380 | Registered | Not determined | None |
| Attencit 80 MG EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 80,0 mg | 80 mg | 51038151/1.2/0381 | Registered | Not determined | None |
| Attencit 100mg EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 100,0 mg | 100mg | 51038251/1.2/0382 | Registered | Not determined | None |
| Xethera 10 MG EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 10,0 mg | 10 mg | 51098851/1.2/0988 | Registered | Not determined | None |
| Xethera 18 MG EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 18,0 mg | 18 mg | 51098951/1.2/0989 | Registered | Not determined | None |
| Xethera 25 MG EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 25,0 mg | 25 mg | 51099051/1.2/0990 | Registered | Not determined | None |
| Xethera 40 MG EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 40,0 mg | 40 mg | 51099151/1.2/0991 | Registered | Not determined | None |
| Xethera 60 MG EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 60,0 mg | 60 mg | 51099251/1.2/0992 | Registered | Not determined | None |
| Xethera 80 MG EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 80,0 mg | 80 mg | 51099351/1.2/0993 | Registered | Not determined | None |
| Atteze 10 EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 10,0 mg | 10 | 51104451/1.2/1044.1038 | Cancelled | Not determined | None |
| Atteze 18 EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 18,0 mg | 18 | 51104551/1.2/1045.1039 | Cancelled | Not determined | None |
| Atteze 25 EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 25,0 mg | 25 | 51104651/1.2/1046.1040 | Cancelled | Not determined | None |
| Atteze 40 EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 40,0 mg | 40 | 51104751/1.2/1047.1041 | Cancelled | Not determined | None |
| Atteze 60 EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 10,0 mg | 60 | 51104851/1.2/1048.1042 | Cancelled | Not determined | None |
| Pellego 40 MG EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 40,0 mg | 40 mg | 530036.03153/1.2/0036.031 | Cancelled | Not determined | None |
| Atomaktin 10 EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 10,0 mg | 10Capsule | 56114156/1.2/1141Approved 29 August 2025 | Registered | S5 | PIPIL |
| Atomaktin 18 EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 18,0 mg | 18Capsule | 56114256/1.2/1142Approved 29 August 2025 | Registered | S5 | PIPIL |
| Atomaktin 25 EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 25,0 mg | 25Capsule | 56114356/1.2/1143Approved 29 August 2025 | Registered | S5 | PIPIL |
| Atomaktin 40 EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 40,0 mg | 40Capsule | 56114456/1.2/1144Approved 29 August 2025 | Registered | S5 | PIPIL |
| Atomaktin 60 EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 60,0 mg | 60Capsule | 56114556/1.2/1145Approved 29 August 2025 | Registered | S5 | PIPIL |
| Atomaktin 80 EACH CAPSULE CONTAINS: ATOMOXETINE HYDROCHLORIDE EQUIVALENT TO ATOMOXETINE 80,0 mg | 80Capsule | 56114656/1.2/1146Approved 29 August 2025 | Registered | S5 | PIPIL |
| Inir 80 Each Capsule contains: Atomoxetine Hydrochloride equivalent to Atomexetine | 80 mgHard gelatin capsules | 57037057/1.2/0370Approved 10 June 2025 | Registered | S5 | PIPIL |
Regulatory status
Where S5 sits on the scale
Prescription-only, with tighter controls on repeats.
Schedule 5 medicines need a prescription, and repeat dispensing is capped at six months in total; the prescriber must state upfront how many times, and at what intervals, it may be repeated. Extra limits apply to some uses: if it is being used for its anxiolytic, antidepressant, tranquillising or analgesic properties, it cannot be prescribed for longer than six months without a further consultation. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S5, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Attentra 10, Teva Pharmaceuticals (Pty) Ltd is scheduled S5 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.